Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model

Experimental Eye Research

Volumn 89, Issue 2, 2009, Pages 193-199

  Ji, Xunda ^a   Zhang, Jufeng ^a   Cheng, Lin ^a   Wei, Fang ^a   Li, Huiming ^a   Liu, Xinjian ^a   Chen, Xiafang ^a   Li, Chuanyuan ^b   Wang, Yufei ^a   Huang, Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

adenoviral vector CRAd; gene therapy; HSVtk GCV; retinoblastoma

Indexed keywords

GANCICLOVIR; ONCOLYTIC ADENOVIRUS; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; EMBRYO; EPITHELIUM CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; RETINOBLASTOMA; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CHILD, PRESCHOOL; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; ONCOLYTIC VIROTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; SIMPLEXVIRUS; THYMIDINE KINASE; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67650409973     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.03.007     Document Type: Article

References (33)

1. Balmer A., Zografos L., and Munier F. Diagnosis and current management of retinoblastoma. Oncogene 25 (2006) 5341-5349
2. Boulton M., and Albon J. Stem cells in the eye. Int. J. Biochem. Cell. Biol. 36 (2004) 643-657
3. Chevez-Barrios P., Chintagumpala M., Mieler W., Paysse E., Boniuk M., Kozinetz C., Hurwitz M.Y., and Hurwitz R.L. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J. Clin. Oncol. 23 (2005) 7927-7935
4. Coussens M., Yamazaki Y., Moisyadi S., Suganuma R., Yanagimachi R., and Allsopp R. Regulation and effects of modulation of telomerase reverse transcriptase expression in primordial germ cells during development. Biol. Reprod. 75 (2006) 785-791
5. Freytag S.O., Stricker H., Pegg J., Paielli D., Pradhan D.G., Peabody J., DePeralta-Venturina M., Xia X., Brown S., Lu M., and Kim J.H. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res. 63 (2003) 7497-7506
6. Hakkarainen T., Hemminki A., Curiel D.T., and Wahlfors J. A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy. Int. J. Mol. Med. 18 (2006) 751-759
7. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., and Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155 (1995) 3711-3715
8. Huang T.G., Savontaus M.J., Shinozaki K., Sauter B.V., and Woo S.L. Telomerase-dependent oncolytic adenovirus for cancer treatment. Gene Ther. 10 (2003) 1241-1247
9. Huang Q., Zhang X., Wang H., Yan B., Kirkpatrick J., Dewhrist M.W., and Li C.Y. A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin. Cancer Res. 10 (2004) 1439-1445
10. Huang P., Watanabe M., Kaku H., Kashiwakura Y., Chen J., Saika T., Nasu Y., Fujiwara T., Urata Y., and Kumon H. Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model. Cancer Gene Ther. 15 (2008) 315-322
11. Hurwitz M.Y., Marcus K.T., Chevez-Barrios P., Louie K., Aguilar-Cordova E., and Hurwitz R.L. Suicide gene therapy for treatment of retinoblastoma in a murine model. Hum. Gene Ther. 10 (1999) 441-448
12. Kanuga N., Winton H.L., Beauchene L., Koman A., Zerbib A., Halford S., Couraud P.O., Keegan D., Coffey P., Lund R.D., Adamson P., and Greenwood J. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest. Ophthalmol. Vis. Sci. 43 (2002) 546-555
13. Kawashima T., Kagawa S., Kobayashi N., Shirakiya Y., Umeoka T., Teraishi F., Taki M., Kyo S., Tanaka N., and Fujiwara T. Telomerase-specific replication-selective virotherapy for human cancer. Clin. Cancer Res. 10 (2004) 285-292
14. Kirn D. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?. Gene Ther. 8 (2001) 89-98
15. Kuppuswamy M., Spencer J.F., Doronin K., Tollefson A.E., Wold W.S., and Toth K. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression. Gene Ther. 12 (2005) 1608-1617
16. Kurihara T., Brough D.E., Kovesdi I., and Kufe D.W. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J. Clin. Invest. 106 (2000) 763-771
17. Lambright E.S., Amin K., Wiewrodt R., Force S.D., Lanuti M., Propert K.J., Litzky L., Kaiser L.R., and Albelda S.M. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther. 8 (2001) 946-953
18. Lanson Jr. N.A., Friedlander P.L., Schwarzenberger P., Kolls J.K., and Wang G. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis. Cancer Res. 63 (2003) 7936-7941
19. Li Y., Chen Y., Dilley J., Arroyo T., Ko D., Working P., and Yu D.C. Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy. Mol. Cancer Ther. 2 (2003) 1003-1009
20. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., and Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. U.S.A 96 (1999) 5147-5152
21. Lohmann D.R., and Gallie B.L. Retinoblastoma: revisiting the model prototype of inherited cancer. Am. J. Med. Genet. C. Semin. Med. Genet. 129C (2004) 23-28
22. Mo Y., Gan Y., Song S., Johnston J., Xiao X., Wientjes M.G., and Au J.L. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res. 63 (2003) 579-585
23. Nanda D., Vogels R., Havenga M., Avezaat C.J., Bout A., and Smitt P.S. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Cancer Res. 61 (2001) 8743-8750
24. Neumann A.A., and Reddel R.R. Telomere maintenance and cancer - look, no telomerase. Nat. Rev. Cancer 2 (2002) 879-884
25. Rodriguez R., Schuur E.R., Lim H.Y., Henderson G.A., Simons J.W., and Henderson D.R. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57 (1997) 2559-2563
26. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 (2005) 1048-1052
27. Shirakawa T. The current status of adenovirus-based cancer gene therapy. Mol. Cells 25 (2008) 462-466
28. Su C., Peng L., Sham J., Wang X., Zhang Q., Chua D., Liu C., Cui Z., Xue H., Wu H., Yang Q., Zhang B., Liu X., Wu M., and Qian Q. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice. Mol. Ther. 13 (2006) 918-927
29. Takahashi M., Sato T., Sagawa T., Lu Y., Sato Y., Iyama S., Yamada Y., Fukaura J., Takahashi S., Miyanishi K., Yamashita T., Sasaki K., Kogawa K., Hamada H., Kato J., and Niitsu Y. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor. Mol. Ther. 5 (2002) 627-634
30. Wagner L.M., Saleh S.M., Boyle D.J., and Takemoto D.J. Effect of protein kinase Cgamma on gap junction disassembly in lens epithelial cells and retinal cells in culture. Mol. Vis. 8 (2002) 59-66
31. Weissleder R., and Pittet M.J. Imaging in the era of molecular oncology. Nature 452 (2008) 580-589
32. Wirth T., Zender L., Schulte B., Mundt B., Plentz R., Rudolph K.L., Manns M., Kubicka S., and Kuhnel F. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res. 63 (2003) 3181-3188
33. Xu H., Wang C., Zhu H., Liu S., Xu X., and Jiang Y. Characteristics of an established retinoblastoma cell line HXO-Rb44. Yan Ke Xue Bao 11 (1995) 16-21